CN1703516A - 制备具有不可皂化物含量降低的微生物脂肪或油的方法和所述脂肪或油 - Google Patents
制备具有不可皂化物含量降低的微生物脂肪或油的方法和所述脂肪或油 Download PDFInfo
- Publication number
- CN1703516A CN1703516A CNA2003801012909A CN200380101290A CN1703516A CN 1703516 A CN1703516 A CN 1703516A CN A2003801012909 A CNA2003801012909 A CN A2003801012909A CN 200380101290 A CN200380101290 A CN 200380101290A CN 1703516 A CN1703516 A CN 1703516A
- Authority
- CN
- China
- Prior art keywords
- acid
- fat
- oil
- oily
- raw oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 86
- 230000008569 process Effects 0.000 title claims abstract description 25
- 230000000813 microbial effect Effects 0.000 title description 5
- 229930182558 Sterol Natural products 0.000 claims abstract description 92
- 235000003702 sterols Nutrition 0.000 claims abstract description 92
- 150000003432 sterols Chemical class 0.000 claims abstract description 91
- 239000000470 constituent Substances 0.000 claims abstract description 55
- 244000005700 microbiome Species 0.000 claims abstract description 55
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims abstract description 52
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims abstract description 52
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 51
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 25
- 239000003925 fat Substances 0.000 claims description 210
- 235000019197 fats Nutrition 0.000 claims description 203
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 claims description 86
- 150000002148 esters Chemical class 0.000 claims description 73
- 238000007670 refining Methods 0.000 claims description 73
- 239000002253 acid Substances 0.000 claims description 68
- 238000002360 preparation method Methods 0.000 claims description 63
- 230000001954 sterilising effect Effects 0.000 claims description 51
- 235000021342 arachidonic acid Nutrition 0.000 claims description 43
- 229940114079 arachidonic acid Drugs 0.000 claims description 43
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 41
- 235000015097 nutrients Nutrition 0.000 claims description 35
- 241000235575 Mortierella Species 0.000 claims description 30
- 235000013305 food Nutrition 0.000 claims description 28
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims description 23
- UNSRRHDPHVZAHH-YOILPLPUSA-N (5Z,8Z,11Z)-icosatrienoic acid Chemical compound CCCCCCCC\C=C/C\C=C/C\C=C/CCCC(O)=O UNSRRHDPHVZAHH-YOILPLPUSA-N 0.000 claims description 19
- UNSRRHDPHVZAHH-UHFFFAOYSA-N 6beta,11alpha-Dihydroxy-3alpha,5alpha-cyclopregnan-20-on Natural products CCCCCCCCC=CCC=CCC=CCCCC(O)=O UNSRRHDPHVZAHH-UHFFFAOYSA-N 0.000 claims description 19
- 241000907999 Mortierella alpina Species 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 18
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 claims description 16
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 claims description 16
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 claims description 16
- 241001465754 Metazoa Species 0.000 claims description 7
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims description 5
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 claims description 4
- 241000228212 Aspergillus Species 0.000 claims description 4
- 241001480517 Conidiobolus Species 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 4
- 241001480508 Entomophthora Species 0.000 claims description 4
- 241000223218 Fusarium Species 0.000 claims description 4
- 241000235395 Mucor Species 0.000 claims description 4
- 241000228143 Penicillium Species 0.000 claims description 4
- 241000233639 Pythium Species 0.000 claims description 4
- 241000223252 Rhodotorula Species 0.000 claims description 4
- 241000233667 Saprolegnia Species 0.000 claims description 4
- HXWJFEZDFPRLBG-UHFFFAOYSA-N Timnodonic acid Natural products CCCC=CC=CCC=CCC=CCC=CCCCC(O)=O HXWJFEZDFPRLBG-UHFFFAOYSA-N 0.000 claims description 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims description 4
- 235000013361 beverage Nutrition 0.000 claims description 4
- 235000013376 functional food Nutrition 0.000 claims description 4
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 4
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 4
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 4
- 229960002733 gamolenic acid Drugs 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 241000251468 Actinopterygii Species 0.000 claims description 3
- 241000222290 Cladosporium Species 0.000 claims description 3
- 235000008098 Oxalis acetosella Nutrition 0.000 claims description 3
- 235000010240 Paullinia pinnata Nutrition 0.000 claims description 3
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 3
- 235000008452 baby food Nutrition 0.000 claims description 3
- 235000015872 dietary supplement Nutrition 0.000 claims description 3
- 229960004488 linolenic acid Drugs 0.000 claims description 3
- 230000002028 premature Effects 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- HQPCSDADVLFHHO-UHFFFAOYSA-N (all-Z)-8,11,14,17-Eicosatetraenoic acid Natural products CCC=CCC=CCC=CCC=CCCCCCCC(O)=O HQPCSDADVLFHHO-UHFFFAOYSA-N 0.000 claims description 2
- ZMKDEQUXYDZSNN-OKLKQMLOSA-N 6E,9E-octadecadienoic acid Chemical compound CCCCCCCC\C=C\C\C=C\CCCCC(O)=O ZMKDEQUXYDZSNN-OKLKQMLOSA-N 0.000 claims description 2
- 241001219832 Lobosporangium Species 0.000 claims description 2
- 241000233614 Phytophthora Species 0.000 claims description 2
- HQPCSDADVLFHHO-LTKCOYKYSA-N all-cis-8,11,14,17-icosatetraenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HQPCSDADVLFHHO-LTKCOYKYSA-N 0.000 claims description 2
- MBMBGCFOFBJSGT-UHFFFAOYSA-N docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CCC=CCC=CCC=CCC=CCC=CCC=CCCC(O)=O MBMBGCFOFBJSGT-UHFFFAOYSA-N 0.000 claims description 2
- ZMKDEQUXYDZSNN-UHFFFAOYSA-N linolelaidic acid Natural products CCCCCCCCC=CCC=CCCCCC(O)=O ZMKDEQUXYDZSNN-UHFFFAOYSA-N 0.000 claims description 2
- 230000007935 neutral effect Effects 0.000 claims description 2
- 210000000664 rectum Anatomy 0.000 claims description 2
- 241001119522 Paullinia pinnata Species 0.000 claims 1
- 239000003921 oil Substances 0.000 abstract description 206
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 17
- 229930195729 fatty acid Natural products 0.000 abstract description 17
- 239000000194 fatty acid Substances 0.000 abstract description 17
- 150000004665 fatty acids Chemical class 0.000 abstract description 15
- 238000013019 agitation Methods 0.000 abstract description 12
- 239000010779 crude oil Substances 0.000 abstract description 2
- 235000019198 oils Nutrition 0.000 description 206
- 239000000243 solution Substances 0.000 description 59
- 239000001963 growth medium Substances 0.000 description 55
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 49
- 238000011218 seed culture Methods 0.000 description 41
- 238000004659 sterilization and disinfection Methods 0.000 description 40
- SPFMQWBKVUQXJV-BTVCFUMJSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;hydrate Chemical compound O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O SPFMQWBKVUQXJV-BTVCFUMJSA-N 0.000 description 34
- 229960000673 dextrose monohydrate Drugs 0.000 description 34
- 210000004027 cell Anatomy 0.000 description 24
- 244000068988 Glycine max Species 0.000 description 20
- 235000010469 Glycine max Nutrition 0.000 description 20
- 239000006052 feed supplement Substances 0.000 description 19
- 229910052799 carbon Inorganic materials 0.000 description 15
- 230000000052 comparative effect Effects 0.000 description 14
- 239000002609 medium Substances 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 230000001413 cellular effect Effects 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 11
- 229960001031 glucose Drugs 0.000 description 11
- 239000008103 glucose Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 238000012258 culturing Methods 0.000 description 10
- 150000002632 lipids Chemical class 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 229940041514 candida albicans extract Drugs 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 239000012138 yeast extract Substances 0.000 description 9
- 150000001721 carbon Chemical group 0.000 description 8
- 238000011081 inoculation Methods 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 238000011534 incubation Methods 0.000 description 6
- 239000001301 oxygen Substances 0.000 description 6
- 229910052760 oxygen Inorganic materials 0.000 description 6
- 238000009423 ventilation Methods 0.000 description 6
- 241000233866 Fungi Species 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 239000012531 culture fluid Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- -1 triglyceride aldehyde Chemical class 0.000 description 5
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004040 coloring Methods 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000001802 infusion Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 235000011121 sodium hydroxide Nutrition 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000001877 deodorizing effect Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 229960004232 linoleic acid Drugs 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229910021654 trace metal Inorganic materials 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- GMVPRGQOIOIIMI-DODZYUBVSA-N 7-[(1R,2R,3R)-3-hydroxy-2-[(3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid Chemical compound CCCCC[C@H](O)C=C[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(O)=O GMVPRGQOIOIIMI-DODZYUBVSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241001674864 Conidiobolus nanodes Species 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 240000007930 Oxalis acetosella Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000645853 Saprolegnia lapponica Species 0.000 description 2
- 238000003723 Smelting Methods 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- DVSZKTAMJJTWFG-UHFFFAOYSA-N docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCCC=CC=CC=CC=CC=CC=CC(O)=O DVSZKTAMJJTWFG-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- DCAYPVUWAIABOU-UHFFFAOYSA-N hexadecane Chemical compound CCCCCCCCCCCCCCCC DCAYPVUWAIABOU-UHFFFAOYSA-N 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 235000021125 infant nutrition Nutrition 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 238000000199 molecular distillation Methods 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000000194 supercritical-fluid extraction Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- XUJWOMMOEOHPFP-UHFFFAOYSA-N (all-Z)-8,11-Eicosadienoic acid Natural products CCCCCCCCC=CCC=CCCCCCCC(O)=O XUJWOMMOEOHPFP-UHFFFAOYSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- XUJWOMMOEOHPFP-OKLKQMLOSA-N 8,11-Eicosadienoic acid Chemical compound CCCCCCCC\C=C\C\C=C\CCCCCCC(O)=O XUJWOMMOEOHPFP-OKLKQMLOSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 241000375384 Cannaboides Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- BDCFUHIWJODVNG-UHFFFAOYSA-N Desmosterol Natural products C1C=C2CC(O)C=CC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 BDCFUHIWJODVNG-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 241000948838 Haliphthoros Species 0.000 description 1
- 241000003482 Japonochytrium Species 0.000 description 1
- 241000907910 Lobosporangium transversale Species 0.000 description 1
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001219224 Mortierella elongata Species 0.000 description 1
- 241000048020 Mortierella exigua Species 0.000 description 1
- 241000133355 Mortierella hygrophila Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 241000233671 Schizochytrium Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FKNQFGJONOIPTF-UHFFFAOYSA-N Sodium cation Chemical compound [Na+] FKNQFGJONOIPTF-UHFFFAOYSA-N 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241001491678 Ulkenia Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 238000009874 alkali refining Methods 0.000 description 1
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- LGEQQWMQCRIYKG-DOFZRALJSA-N anandamide Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)NCCO LGEQQWMQCRIYKG-DOFZRALJSA-N 0.000 description 1
- LGEQQWMQCRIYKG-UHFFFAOYSA-N arachidonic acid ethanolamide Natural products CCCCCC=CCC=CCC=CCC=CCCCC(=O)NCCO LGEQQWMQCRIYKG-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 230000003570 biosynthesizing effect Effects 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 229930003827 cannabinoid Natural products 0.000 description 1
- 239000003557 cannabinoid Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229910001429 cobalt ion Inorganic materials 0.000 description 1
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical compound [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- AVSXSVCZWQODGV-DPAQBDIFSA-N desmosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@@H](CCC=C(C)C)C)[C@@]1(C)CC2 AVSXSVCZWQODGV-DPAQBDIFSA-N 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000012489 doughnuts Nutrition 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 108010025899 gelatin film Proteins 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 229910001425 magnesium ion Inorganic materials 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229910001453 nickel ion Inorganic materials 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229940085991 phosphate ion Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 229940001516 sodium nitrate Drugs 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000007669 thermal treatment Methods 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229960003487 xylose Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6472—Glycerides containing polyunsaturated fatty acid [PUFA] residues, i.e. having two or more double bonds in their backbone
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/232—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having three or more double bonds, e.g. etretinate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nutrition Science (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Edible Oils And Fats (AREA)
Abstract
Description
主要培养时间 | 培养基补料 |
19小时后 | 一水合葡萄糖280kg/460L |
43小时后 | 一水合葡萄糖280kg/450L |
67小时后 | 一水合葡萄糖252kg/390L |
91小时后 | 一水合葡萄糖252kg/410L |
120小时后 | 一水合葡萄糖224kg/370L |
140小时后 | 一水合葡萄糖168kg/280L |
163小时后 | 一水合葡萄糖168kg/270L |
实施例 | 实施例1条件1-1 | 实施例1条件1-2 |
培养箱的形式,d/D | 0.34 | 0.34 |
调节培养基A的pH值(灭菌前)培养基C的pH值(灭菌后和种子培养液接种前) | 6.36.3 | 4.56.3 |
每个级分的重量百分比甘油三酯不可皂化物酯型甾醇 | 94.0%2.0%0.8% | 94.2%1.8%0.6% |
粗制油中总脂肪酸中的花生四烯酸,% | 42.0% | 42.1% |
实施例 | 实施例2条件2-1 | 实施例2条件2-2 |
培养箱的形式,d/D | 0.42 | 0.42 |
调节培养基A的pH值(灭菌前)培养基C的pH值(灭菌后和种子培养液接种前) | 6.16.1 | 4.56.1 |
每个级分的重量百分比甘油三酯不可皂化物酯型甾醇 | 94.2%1.8%0.6% | 93.5%1.6%0.5% |
粗制油中总脂肪酸中的花生四烯酸,% | 42.2% | 41.3% |
实施例或对照实施例 | 实施例3对照实施例 | 实施例3对照实施例 | 实施例3对照实施例 |
培养箱的形式,d/D | 0.30 | 0.25 | 0.20 |
调节培养基A的pH值(灭菌前)培养基C的pH值(灭菌后和种子培养液接种前) | 6.36.3 | 6.36.3 | 6.36.3 |
每个级分的重量百分比甘油三酯不可皂化物酯型甾醇 | 93.8%2.9%1.2% | 93.1%2.9%1.2% | 93.0%2.9%1.2% |
粗制油中总脂肪酸中的花生四烯酸,% | 42.0% | 41.6% | 41.5% |
实施例或对照实施例 | 实施例4条件4-1 | 实施例4条件4-2(对照实施例) | 实施例4条件4-3(对照实施例) | 实施例4条件4-4 | 实施例4条件4-5 |
培养箱的形式,d/D | 0.30 | 0.25 | 0.20 | 0.30 | 0.30 |
调节培养基A的pH值(灭菌前)培养基C的pH值(灭菌后和种子培养液接种前) | 4.56.3 | 4.56.3 | 4.56.3 | 4.06.3 | 4.96.3 |
每个级分的重量百分比甘油三酯不可皂化物酯型甾醇 | 93.8%2.2%1.0% | 93.1%2.5%1.1% | 93.0%2.7%1.1% | 93.5%2.1%1.0% | 93.4%2.1%1.0% |
粗制油中总脂肪酸中的花生四烯酸,% | 42.0% | 40.8% | 40.8% | 41.5% | 41.7% |
实施例或对照实施例 | 实施例1(条件1-1) | 实施例2(条件2-1) | 实施例3(d/D=0.25)(对照实施例) |
精炼脂肪或油 | 5-A | 5-B | 5-C |
每个级分的重量百分比甘油三酯不可皂化物酯型甾醇 | 96.0%1.4%0.8% | 96.4%1.2%0.6% | 95.0%2.0%1.2% |
粗制油中总脂肪酸中的花生四烯酸,% | 42.4% | 42.8% | 41.7% |
主要培养时间 | 培养基补料 |
19小时后 | 一水合葡萄糖84kg/200L |
43小时后 | 一水合葡萄糖84kg/200L |
67小时后 | 一水合葡萄糖56kg/120L |
91小时后 | 一水合葡萄糖56kg/125L |
培养箱的形式,d/D | 0.25 | 0.34 |
每个级分的重量百分比甘油三酯不可皂化物酯型甾醇 | 94.1%1.2%0.4% | 93.0%1.2%0.4% |
粗制油中总脂肪酸中的花生四烯酸,% | 40.8% | 41.5% |
主要培养时间 | 培养基补料 |
19小时后 | 一水合葡萄糖280kg/460L |
43小时后 | 一水合葡萄糖280kg/450L |
67小时后 | 一水合葡萄糖280kg/450L |
120小时后 | 一水合葡萄糖336kg/530L |
实施例或对照实施例 | 实施例7条件7-1 | 实施例7条件7-2 | 实施例7条件7-3(对照实施例) | 实施例7条件7-4(对照实施例) |
培养箱的形式,d/D | 0.34 | 0.30 | 0.30 | 0.25 |
调节培养基A的pH值(灭菌前)培养基C的pH值(灭菌后和种子培养液接种前) | 6.16.1 | 4.56.1 | 6.16.1 | 6.16.1 |
每个级分的重量百分比甘油三酯不可皂化物酯型甾醇 | 93.8%2.1%0.9% | 94.1%2.2%1.0% | 93.5%2.9%1.2% | 93.0%2.9%1.2% |
粗制油中总脂肪酸中的二高-γ-亚麻酸,% | 42.2% | 41.9% | 40.7% | 41.7% |
主要培养时间 | 培养基补料 |
19小时后 | 一水合葡萄糖84kg/200L |
43小时后 | 一水合葡萄糖84kg/200L |
67小时后 | 一水合葡萄糖84kg/120L |
91小时后 | 一水合葡萄糖84kg/125L |
培养箱的形式,d/D | 0.25 | 0.34 |
每个级分的重量百分比甘油三酯不可皂化物酯型甾醇 | 93.5%1.2%0.4% | 93.0%1.2%0.4% |
粗制油中总脂肪酸中的二高-γ-亚麻酸,% | 40.5% | 41.3% |
主要培养时间 | 培养基补料 |
19小时后 | 一水合葡萄糖160kg/280L |
43小时后 | 一水合葡萄糖160kg/280L |
67小时后 | 一水合葡萄糖120kg/210L |
91小时后 | 一水合葡萄糖120kg/210L |
144小时后 | 一水合葡萄糖80kg/140L |
实施例或对照实施例 | 实施例9 | 实施例10(对照实施例) |
培养箱的形式,d/D | 0.5 | 0.25 |
每个级分的重量百分比甘油三酯不可皂化物酯型甾醇 | 94.6%1.8%0.6% | 93.0%2.8%1.2% |
粗制油中总脂肪酸中的Mead acid,% | 35.0% | 30.6% |
主要培养时间 | 培养基补料 |
19小时后 | 一水合葡萄糖60kg/120L |
43小时后 | 一水合葡萄糖60kg/120L |
67小时后 | 一水合葡萄糖40kg/80L |
91小时后 | 一水合葡萄糖40kg/80L |
培养箱的形式,d/D | 0.25 | 0.34 |
每个级分的重量百分比甘油三酯不可皂化物酯型甾醇 | 95.0%1.3%0.5% | 95.1%1.3%0.5% |
粗制油中总脂肪酸中的Mead acid,% | 34.5% | 34.2% |
菌株 | 长形被孢霉IFO 8570 | 喜湿被孢霉IFO 5941 | 横断刺孢囊霉NRRL 3116 | C.nanodesCBS 154.56 | S.lapponicaCBS 284.38 |
每个级分的重量百分比甘油三酯不可皂化物酯型甾醇 | 90.0%1.9%0.8% | 88.1%1.9%0.7% | 86.0%2.0%0.7% | 83.4%2.0%0.8% | 82.6%2.0%0.8% |
粗制油中总脂肪酸中的花生四烯酸,% | 30.8% | 31.7% | 28.6% | 26.3% | 20.7% |
Claims (22)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011033675.8A CN112176006A (zh) | 2002-10-11 | 2003-10-09 | 制备具有不可皂化物含量降低的微生物油脂的方法和所述油脂 |
CN201510998222.1A CN105586370A (zh) | 2002-10-11 | 2003-10-09 | 制备具有不可皂化物含量降低的微生物油脂的方法和所述油脂 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002299199 | 2002-10-11 | ||
JP299199/2002 | 2002-10-11 |
Related Child Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510998222.1A Division CN105586370A (zh) | 2002-10-11 | 2003-10-09 | 制备具有不可皂化物含量降低的微生物油脂的方法和所述油脂 |
CNA2008100908891A Division CN101310622A (zh) | 2002-10-11 | 2003-10-09 | 制备具有不可皂化物含量降低的微生物油脂的方法和所述油脂 |
CN202011033675.8A Division CN112176006A (zh) | 2002-10-11 | 2003-10-09 | 制备具有不可皂化物含量降低的微生物油脂的方法和所述油脂 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1703516A true CN1703516A (zh) | 2005-11-30 |
Family
ID=32089335
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2003801012909A Pending CN1703516A (zh) | 2002-10-11 | 2003-10-09 | 制备具有不可皂化物含量降低的微生物脂肪或油的方法和所述脂肪或油 |
CNA2008100908891A Pending CN101310622A (zh) | 2002-10-11 | 2003-10-09 | 制备具有不可皂化物含量降低的微生物油脂的方法和所述油脂 |
CN202011033675.8A Pending CN112176006A (zh) | 2002-10-11 | 2003-10-09 | 制备具有不可皂化物含量降低的微生物油脂的方法和所述油脂 |
CN201510998222.1A Pending CN105586370A (zh) | 2002-10-11 | 2003-10-09 | 制备具有不可皂化物含量降低的微生物油脂的方法和所述油脂 |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2008100908891A Pending CN101310622A (zh) | 2002-10-11 | 2003-10-09 | 制备具有不可皂化物含量降低的微生物油脂的方法和所述油脂 |
CN202011033675.8A Pending CN112176006A (zh) | 2002-10-11 | 2003-10-09 | 制备具有不可皂化物含量降低的微生物油脂的方法和所述油脂 |
CN201510998222.1A Pending CN105586370A (zh) | 2002-10-11 | 2003-10-09 | 制备具有不可皂化物含量降低的微生物油脂的方法和所述油脂 |
Country Status (18)
Country | Link |
---|---|
US (1) | US7709236B2 (zh) |
EP (4) | EP1549753B1 (zh) |
JP (2) | JP4761771B2 (zh) |
KR (4) | KR101460259B1 (zh) |
CN (4) | CN1703516A (zh) |
AT (1) | ATE480633T1 (zh) |
AU (1) | AU2003272095B2 (zh) |
CA (1) | CA2501880C (zh) |
CY (2) | CY1116869T1 (zh) |
DE (1) | DE60334129D1 (zh) |
DK (3) | DK2966172T3 (zh) |
ES (3) | ES2550468T3 (zh) |
HK (2) | HK1219759A1 (zh) |
HU (2) | HUE026450T2 (zh) |
MY (1) | MY148374A (zh) |
SI (2) | SI2267142T1 (zh) |
TW (2) | TWI352121B (zh) |
WO (1) | WO2004033698A2 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113766836A (zh) * | 2018-09-14 | 2021-12-07 | 费尔曼塔格公司 | 富含二十二碳六烯酸的微生物油 |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE20100662U1 (de) * | 2001-01-15 | 2001-04-19 | Salice Arturo Spa | Hebevorrichtung für eine zweiflügelige Faltklappe |
JP2006061021A (ja) * | 2004-08-24 | 2006-03-09 | Suntory Ltd | 1種類の高度不飽和脂肪酸残基3個から成るトリグリセライドの製造方法、およびその利用 |
JP4624040B2 (ja) * | 2004-09-06 | 2011-02-02 | 日本水産株式会社 | 菌体培養方法 |
JP4575105B2 (ja) * | 2004-10-07 | 2010-11-04 | ポリエン・プロジェクト有限会社 | 骨芽細胞活性抑制剤 |
JP5658876B2 (ja) * | 2006-07-05 | 2015-01-28 | フォトンズ コーポレーション リミテッド | 大規模従属栄養培養領域にて産生される超高純度epaと極性脂質 |
US8207363B2 (en) | 2009-03-19 | 2012-06-26 | Martek Biosciences Corporation | Thraustochytrids, fatty acid compositions, and methods of making and uses thereof |
US8399226B2 (en) * | 2009-06-16 | 2013-03-19 | E I Du Pont De Nemours And Company | High eicosapentaenoic acid oils from improved optimized strains of Yarrowia lipolytica |
RU2014146265A (ru) | 2009-12-30 | 2015-07-10 | Басф Фарма (Калланиш) Лимитед | Способ хроматографического разделения с псевдодвижущимся слоем |
BR122015020119B8 (pt) | 2010-01-19 | 2021-05-04 | Dsm Ip Assets Bv | óleo microbiano, produtos alimentícios para um animal não humano e biomassa isolada |
CN101914581B (zh) * | 2010-07-27 | 2012-05-23 | 南京工业大学 | 一种提高多烯不饱和脂肪酸发酵产量的方法 |
JP5416861B2 (ja) * | 2011-03-03 | 2014-02-12 | 日本水産株式会社 | リパーゼによる高度不飽和脂肪酸含有油脂の製造方法 |
GB201111589D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New modified process |
GB201111595D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | Improved process |
GB201111591D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | Further new process |
GB201111594D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New improved process |
GB201111601D0 (en) | 2011-07-06 | 2011-08-24 | Equateq Ltd | New process |
AU2012285806B2 (en) | 2011-07-21 | 2017-09-14 | Dsm Ip Assets B.V. | Fatty acid compositions |
BR112014015367A2 (pt) * | 2011-12-27 | 2017-07-04 | Bp Corp North America Inc | óleos biológicos para uso em motores de compressão e métodos para produzir tais óleos |
KR20140116845A (ko) * | 2012-01-13 | 2014-10-06 | 도레이 카부시키가이샤 | 화학품의 제조방법 |
BR112014017006A8 (pt) * | 2012-01-13 | 2017-07-04 | Toray Industries | método para produzir um produto químico por fermentação contínua |
JP6081733B2 (ja) * | 2012-08-08 | 2017-02-15 | 高砂熱学工業株式会社 | 炭化水素を生産可能な微生物からのオイル製造方法、及び製造システム |
GB201300354D0 (en) | 2013-01-09 | 2013-02-20 | Basf Pharma Callanish Ltd | Multi-step separation process |
US8802880B1 (en) | 2013-05-07 | 2014-08-12 | Group Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
US9428711B2 (en) | 2013-05-07 | 2016-08-30 | Groupe Novasep | Chromatographic process for the production of highly purified polyunsaturated fatty acids |
EP2826384A1 (de) | 2013-07-16 | 2015-01-21 | Evonik Industries AG | Verfahren zur Trocknung von Biomasse |
ES2875965T3 (es) | 2013-12-04 | 2021-11-11 | Nippon Suisan Kaisha Ltd | Aceite microbiano que contiene ácido dihomo-gamma-linolénico y biomasa microbiana que contiene ácido dihomo-gamma-linolénico |
EP2883860B1 (fr) | 2013-12-11 | 2016-08-24 | Novasep Process | Procédé chromatographique de production d'acides gras polyinsaturés |
EP3092218B1 (fr) | 2014-01-07 | 2022-03-09 | Novasep Process Solutions | Procédé de purification d'acides aminés aromatiques |
US11464244B2 (en) | 2014-10-02 | 2022-10-11 | Evonik Operations Gmbh | Feedstuff of high abrasion resistance and good stability in water, containing PUFAs |
DK179981B1 (en) | 2014-10-02 | 2019-11-29 | Evonik Degussa Gmbh | Process for producing a PUFA-containing feedstuff by extruding a PUFA-containing biomass |
DK180021B1 (en) | 2014-10-02 | 2020-01-22 | Evonik Degussa Gmbh | Process for producing a PUFA-containing biomass which has high cell stability. |
DK179843B1 (en) | 2014-10-02 | 2019-07-31 | Evonik Degussa Gmbh | Method for raising animals |
MY158177A (en) * | 2014-12-04 | 2016-09-06 | Univ Putra Malaysia | Antioxidant and/or antimicrobial composition based on palm oil |
KR101989468B1 (ko) * | 2017-06-22 | 2019-06-14 | 성균관대학교 산학협력단 | 줄기세포 배양용 기판의 제조방법 |
CN111534362A (zh) * | 2020-03-28 | 2020-08-14 | 蚌埠市江淮粮油有限公司 | 一种米糠油的提取方法 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0716424B2 (ja) | 1985-10-01 | 1995-03-01 | ライオン株式会社 | アラキドン酸含有脂質の製造方法 |
JPH0734752B2 (ja) | 1986-03-31 | 1995-04-19 | サントリー株式会社 | アラキドン酸及びこれを含有する脂質の製造方法 |
JP2810560B2 (ja) | 1991-05-16 | 1998-10-15 | 住友重機械工業株式会社 | 高粘性発酵液の通気撹拌方法 |
JP3354582B2 (ja) | 1991-09-30 | 2002-12-09 | サントリー株式会社 | オメガ9系高度不飽和脂肪酸およびこれを含有する脂質の製造方法 |
JP3354581B2 (ja) | 1991-09-30 | 2002-12-09 | サントリー株式会社 | ジホモ−γ−リノレン酸及びこれを含有する脂質の製造方法 |
JPH06105680A (ja) | 1992-09-29 | 1994-04-19 | Sumitomo Pharmaceut Co Ltd | 動物細胞の培養方法および培養装置 |
JP3354608B2 (ja) * | 1992-11-16 | 2002-12-09 | サントリー株式会社 | 高度不飽和脂肪酸及びこれを含有する脂質の製造方法 |
JPH09220457A (ja) | 1996-02-16 | 1997-08-26 | Bio Polymer Res:Kk | 高非ニュートン流体攪拌用門型羽根 |
EP1506996A3 (en) | 1996-03-28 | 2006-06-14 | DSM IP Assets B.V. | Preparation of microbial polyunsaturated fatty acid containing oil from pasteurised biomass |
DK0904339T4 (da) * | 1996-05-15 | 2007-01-29 | Dsm Ip Assets Bv | Sterolekstraktion med et polært oplösningsmiddel til opnåelse af lavsterolholdig mikrobiel olie |
JP2958513B2 (ja) | 1996-07-04 | 1999-10-06 | 日本ヒューム管株式会社 | 管路の内面止水方法及びその方法に使用する止め金装着装置 |
JP3995290B2 (ja) | 1996-08-23 | 2007-10-24 | サントリー株式会社 | オメガ9系高度不飽和脂肪酸及びそれを含有する脂質の製造方法 |
JP3792309B2 (ja) | 1996-08-30 | 2006-07-05 | サントリー株式会社 | 不飽和脂肪酸含有油脂の製造方法 |
JP4633204B2 (ja) * | 1996-10-11 | 2011-02-16 | サントリーホールディングス株式会社 | アラキドン酸含有食用油脂およびそれを含有する食品 |
WO1998039468A1 (fr) | 1997-03-04 | 1998-09-11 | Suntory Limited | Procede pour preparer un acide gras hautement insature (aghi) et lipide contenant cet aghi |
-
2003
- 2003-10-09 TW TW092128123A patent/TWI352121B/zh not_active IP Right Cessation
- 2003-10-09 EP EP03754068A patent/EP1549753B1/en not_active Expired - Lifetime
- 2003-10-09 SI SI200332447T patent/SI2267142T1/sl unknown
- 2003-10-09 EP EP17209854.3A patent/EP3336193A1/en active Pending
- 2003-10-09 CN CNA2003801012909A patent/CN1703516A/zh active Pending
- 2003-10-09 KR KR1020127031545A patent/KR101460259B1/ko active IP Right Grant
- 2003-10-09 CA CA2501880A patent/CA2501880C/en not_active Expired - Lifetime
- 2003-10-09 EP EP10009159.4A patent/EP2267142B1/en not_active Expired - Lifetime
- 2003-10-09 HU HUE10009159A patent/HUE026450T2/en unknown
- 2003-10-09 KR KR1020147017753A patent/KR101451415B1/ko active IP Right Grant
- 2003-10-09 US US10/530,747 patent/US7709236B2/en active Active
- 2003-10-09 AT AT03754068T patent/ATE480633T1/de not_active IP Right Cessation
- 2003-10-09 DK DK15177837.0T patent/DK2966172T3/en active
- 2003-10-09 HU HUE15177837A patent/HUE037467T2/hu unknown
- 2003-10-09 AU AU2003272095A patent/AU2003272095B2/en not_active Expired
- 2003-10-09 DE DE60334129T patent/DE60334129D1/de not_active Expired - Lifetime
- 2003-10-09 MY MYPI20033847A patent/MY148374A/en unknown
- 2003-10-09 JP JP2004542863A patent/JP4761771B2/ja not_active Expired - Lifetime
- 2003-10-09 ES ES10009159.4T patent/ES2550468T3/es not_active Expired - Lifetime
- 2003-10-09 TW TW099130181A patent/TWI352122B/zh not_active IP Right Cessation
- 2003-10-09 CN CNA2008100908891A patent/CN101310622A/zh active Pending
- 2003-10-09 SI SI200332562T patent/SI2966172T1/en unknown
- 2003-10-09 KR KR1020057006276A patent/KR101175773B1/ko active IP Right Grant
- 2003-10-09 DK DK10009159.4T patent/DK2267142T3/en active
- 2003-10-09 KR KR1020117031709A patent/KR20120023151A/ko active Application Filing
- 2003-10-09 DK DK03754068.9T patent/DK1549753T3/da active
- 2003-10-09 ES ES03754068T patent/ES2350926T3/es not_active Expired - Lifetime
- 2003-10-09 CN CN202011033675.8A patent/CN112176006A/zh active Pending
- 2003-10-09 EP EP15177837.0A patent/EP2966172B1/en not_active Expired - Lifetime
- 2003-10-09 ES ES15177837.0T patent/ES2661674T3/es not_active Expired - Lifetime
- 2003-10-09 CN CN201510998222.1A patent/CN105586370A/zh active Pending
- 2003-10-09 WO PCT/JP2003/013000 patent/WO2004033698A2/en active Application Filing
-
2011
- 2011-02-09 JP JP2011026303A patent/JP2011139707A/ja active Pending
-
2015
- 2015-10-29 CY CY20151100966T patent/CY1116869T1/el unknown
-
2016
- 2016-07-06 HK HK16107824.9A patent/HK1219759A1/zh not_active IP Right Cessation
-
2018
- 2018-05-18 CY CY20181100513T patent/CY1120231T1/el unknown
- 2018-12-18 HK HK18116246.8A patent/HK1257077A1/zh unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113766836A (zh) * | 2018-09-14 | 2021-12-07 | 费尔曼塔格公司 | 富含二十二碳六烯酸的微生物油 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1703516A (zh) | 制备具有不可皂化物含量降低的微生物脂肪或油的方法和所述脂肪或油 | |
DK1513941T3 (en) | PREPARATION OF MICROBIAL OILS CONTAINING MULTI-Saturated FAT ACIDS | |
EP1513941B1 (en) | Preparation of microbial oil containing polyunsaturated fatty acids | |
CN1200109C (zh) | 含不饱和脂肪酸油脂的制造方法 | |
CN1696300A (zh) | 花生四烯酸及其生产和使用方法 | |
CN100588713C (zh) | 转酯的油/脂肪或甘油三酯的生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SUNTORY HOLDINGS CO., LTD. Free format text: FORMER OWNER: SUNTORY LTD. Effective date: 20090703 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20090703 Address after: Osaka Applicant after: Suntory Holdings Limited Address before: Osaka Applicant before: Suntory Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: JAPAN FISHERIES CO., LTD. Free format text: FORMER OWNER: SUNTORY HOLDINGS CO., LTD. Effective date: 20100511 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: OSAKA, JAPAN TO: TOKYO, JAPAN |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100511 Address after: Tokyo, Japan Applicant after: Nippon Suisan Kaisha Address before: Osaka Applicant before: Suntory Holdings Limited |
|
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20051130 |